Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap6.10B
EV6.10B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
79.3
63.5
50.4
86.0
148.9
155.3
117.8
117.9
126.2
127.5
Revenue % Chg.
-9.0%
-19.9%
-20.6%
70.6%
73.1%
4.3%
-24.1%
0.1%
7.0%
16.3%
Cost of Revenue
5.2
6.0
5.6
6.6
7.3
8.4
8.6
15.4
18.4
17.8
Gross Profit
74.1
57.5
44.9
79.5
141.6
146.9
109.2
102.5
107.9
109.7
Gross Profit Margin
93.5%
90.5%
89.0%
92.4%
95.1%
94.6%
92.7%
86.9%
85.4%
86.0%
R&D Expenses
—
5.6
5.6
4.7
11.7
15.8
13.6
14.9
12.6
13.3
Selling, General, & Admin Expenses
49.0
24.3
12.0
43.6
89.8
94.1
72.5
61.7
66.5
67.0
Other Expenses
1.2
3.6
3.6
3.3
1.7
1.8
1.4
6.6
8.8
8.7
Operating Income
23.9
24.0
23.7
27.9
38.4
43.6
30.6
28.0
20.5
17.8
Operating Income Margin
30.1%
37.8%
46.9%
32.4%
25.8%
28.1%
26.0%
23.7%
16.2%
13.9%
Total Other Income/Expenses Net
5.2
8.4
8.1
55.9
5.3
-0.1
-0.3
-0.5
-0.1
-0.2
Income Before Tax
29.1
32.4
31.8
83.8
43.7
43.6
30.3
27.5
20.4
17.6
Income Before Tax Margin
36.6%
51.0%
63.0%
97.4%
29.4%
28.1%
25.7%
23.3%
16.2%
13.8%
Income Tax Expense
3.4
4.0
3.9
14.1
5.3
4.8
3.6
3.1
2.4
2.6
Net Income
25.6
28.4
27.9
69.7
38.4
38.8
26.7
21.6
14.8
13.4
Net Income Margin
32.3%
44.8%
55.4%
81.1%
25.8%
25.0%
22.7%
18.3%
11.7%
10.5%
Weighted Avg. Shares Out
119.7
119.8
119.8
120.0
133.3
160.3
159.4
157.4
156.1
156.5
EPS
0.2
0.2
0.2
0.6
0.3
0.2
0.2
0.1
0.1
0.1
EPS % Chg.
48.5%
10.9%
-1.8%
149.4%
-50.4%
-16.2%
-30.7%
-18.3%
-30.9%
-49.7%
Weighted Avg. Shares Out Dil
119.7
119.8
119.8
120.0
133.3
160.3
159.4
157.4
156.1
156.5
EPS Diluted
0.2
0.2
0.2
0.6
0.3
0.2
0.2
0.1
0.1
0.1
Interest Income
—
0.0
0.1
1.6
5.1
9.1
7.1
3.6
2.7
2.9
Interest Expense
-0.1
—
—
1.6
5.1
-6.5
0.1
0.2
0.1
0.1
EBIT
29.1
32.4
31.9
83.8
43.7
59.2
37.3
30.9
23.0
20.4
EBIT Margin
36.7%
51.0%
63.3%
97.4%
29.4%
38.1%
31.7%
26.2%
18.2%
16.0%
Depreciation & Amortization
3.2
3.6
3.9
3.9
5.0
-1.5
3.8
4.9
6.6
1.0
EBITDA
32.4
36.1
35.8
87.7
48.8
57.6
41.1
35.8
29.6
21.4
EBITDA Margin
40.8%
56.8%
71.0%
102.0%
32.8%
37.1%
34.9%
30.3%
23.5%
16.8%